Key result
Mutation of the RGD motif of IGFBP-2 into an RGE sequence did not alter in vivo cell surface association or growth inhibitory effects of elevated IGFBP-2 in transgenic mice.
The RGD motif of IGFBP-2 is not required for its cell surface association or growth inhibitory effects in vivo.
This is the authors' abstract. We don't add key points for this paper.
Using insulin-like growth factor-binding protein-2 (IGFBP-2) transgenic mice (D mice) as a model of elevated IGFBP-2 expression, which is often found in unphysiological conditions, we found association of IGFBP-2 to purified plasma membranes of many organs. To determine whether the RGD (Arg-Gly-Asp) motif of IGFBP-2 mediates cell surface binding in vivo, we mutated the RGD motif of IGFBP-2 into an RGE (Arg-Gly-Glu) sequence and produced transgenic mice (E mice) which express elevated amounts of mutated IGFBP-2. Our data demonstrate that in vivo IGFBP-2 cell surface association is not dependent on the RGD motif and that mutation of this sequence does not alter growth inhibitory effects of IGFBP-2.
Answers are grounded in this paper and cite their sources.
RGD motif dispensable for IGFBP-2 effects in transgenic mice; leaves open its relevance in human cardiovascular models.
No takes yet. Share an insight, caveat, or question.
Hoeflich et al. (2002) studied Elevated IGFBP-2 expression. Mutation of the RGD motif of IGFBP-2 into an RGE sequence vs. Transgenic mice expressing elevated amounts of wild-type IGFBP-2 (D mice) was evaluated on IGFBP-2 cell surface association and growth inhibitory effects. Mutation of the RGD motif of IGFBP-2 into an RGE sequence did not alter in vivo cell surface association or growth inhibitory effects of elevated IGFBP-2 in transgenic mice.
Synapse has enriched 10 related papers. Consider them for comparative context: